ArticleCell cycle (Georgetown, Tex.)2022

Statement of Retraction: The lncRNA RHPN1-AS1 downregulation promotes gefitinib resistance by targeting miR-299-3p/TNFSF12 pathway in NSCLC.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.